JMP Clinical at CDISC European Interchange

Every year, the Clinical Data Interchange Standards Consortium (CDISC) holds several Interchange events that take place in the US, Europe and Asia. These meetings have several goals: to give CDISC users the opportunity to present solutions to data challenges that arise in the day-to-day use of these standards; to provide new or [...]

Post a Comment

JMP Genomics shows the future of biomarker discovery

The Biomarkers Congress is Europe’s largest biomarkers event showcasing case studies in biomarker discovery, and validation strategies and regulation. Its industry delegate list reads like a who’s who in the world of biomarkers, with representation from throughout the globe, for example, AstraZeneca, GSK, Merck, Roche and Takeda. It was fantastic [...]

Post a Comment

JMP Genomics at Plant & Animal Genomes meeting

The JMP booth at the Plant and Animal Genomes (PAG) meeting was a constant blur of activity this week in San Diego. Over three days, we talked with more than 100 researchers, all working to improve our knowledge of many different kinds of plants and animals. We talked with scientists [...]

Post a Comment

JMP Clinical present at PhUSE, Brighton 2011

The Pharmaceutical Users Software Exchange (PhUSE) conference in the British seaside resort of Brighton was nearly two months ago, but I am still thinking about it; PhUSE provided an opportunity to learn from experts and share ideas about the application of software in the pharmaceutical industry. The theme for this [...]

Post a Comment

Accounting for the time at which an adverse event occurs

In a previous post, I described how JMP Clinical allows you to specify time windows within an incidence analysis. Specifying time windows can provide a more informative analysis since it is possible to view how the risk of adverse events (AEs) changes over the course of a clinical trial. However, the [...]

Post a Comment

Customizing and extending analytics with add-ins

Wayne Levin is part of a group of engineers, statisticians and programmers who are passionate about expanding the use of statistical methods to improve productivity, quality and yields. That group is Predictum, and Wayne is president. How exactly does Predictum help companies improve productivity, quality and yields? “We do this [...]

Post a Comment

Summarizing the incidence of adverse events

The analysis of adverse events (AEs) suffers from the problem of dimensionality. It is impossible to predict what AEs will occur on study, and there are often numerous events by study’s end. Typically, the incidence of adverse events is summarized in tables, with events coded by a medical dictionary, such [...]

Post a Comment

What’s ‘hot’ in research? Genetics

What’s the hottest area of scientific research today? Thomson Reuters Science Watch says it’s genetics. In an article titled “The Softer Side of Genomics,” Drug Discovery & Development magazine describes how today’s data management and computational tools let researchers dig deeper into genes. The article describes JMP Genomics, emphasizing its [...]

Post a Comment

JMP Clinical 3.1 generates adverse event narratives

In a clinical trial, when a subject has a serious adverse event (SAE) or other significant adverse event (AE), such as those leading to the discontinuation of the study, a narrative is written for the clinical study report. These narratives summarize the details surrounding the event to enable understanding of [...]

Post a Comment

Great things happen when users are partners in software development process

Now it’s time to follow up my earlier blog post about JMP Genomics user Dr. Eric Jackson winning the Herbert L. Rothbart Outstanding Early Career Research Scientist, a national award for USDA-ARS. I wanted to share some of our team’s experiences that speak to Eric’s creativity and energy as a [...]

Post a Comment